IVERIC BIO INC's ticker is ISEE and the CUSIP is 46583P102. A total of 121 filers reported holding IVERIC BIO INC in Q2 2020. The put-call ratio across all filers is 1.01 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $7,614,847 | +2908.0% | 193,565 | +1537.1% | 0.02% | +2200.0% |
| Q4 2022 | $253,152 | -75.5% | 11,824 | -79.5% | 0.00% | -80.0% |
| Q3 2022 | $1,034,000 | +137.7% | 57,663 | +27.6% | 0.01% | +150.0% |
| Q2 2022 | $435,000 | -42.4% | 45,201 | +0.1% | 0.00% | 0.0% |
| Q4 2021 | $755,000 | -45.8% | 45,155 | -47.3% | 0.00% | -50.0% |
| Q3 2021 | $1,392,000 | +145.1% | 85,684 | -4.8% | 0.00% | +100.0% |
| Q2 2021 | $568,000 | -3.6% | 90,007 | -5.5% | 0.00% | -33.3% |
| Q1 2021 | $589,000 | +47.6% | 95,237 | +64.9% | 0.00% | 0.0% |
| Q4 2020 | $399,000 | +118.0% | 57,756 | +60.9% | 0.00% | 0.0% |
| Q2 2020 | $183,000 | -37.3% | 35,892 | -57.7% | 0.00% | -57.1% |
| Q1 2020 | $292,000 | +1.4% | 84,855 | +153.0% | 0.01% | +250.0% |
| Q4 2019 | $288,000 | +1700.0% | 33,545 | +167.1% | 0.00% | – |
| Q2 2019 | $16,000 | – | 12,557 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| COMMODORE CAPITAL LP | 1,729,041 | $10,685,000 | 4.26% |
| Soleus Capital Management, L.P. | 3,380,979 | $20,894,000 | 3.76% |
| ACUTA CAPITAL PARTNERS, LLC | 1,579,093 | $9,759,000 | 3.52% |
| Stonepine Capital Management, LLC | 875,180 | $5,409,000 | 2.92% |
| Samsara BioCapital, LLC | 2,372,476 | $14,664,000 | 2.70% |
| Ghost Tree Capital, LLC | 1,125,000 | $6,953,000 | 1.63% |
| Octagon Capital Advisors LP | 680,036 | $4,203,000 | 1.58% |
| Altium Capital Management LP | 902,633 | $5,578,000 | 1.55% |
| Vivo Capital, LLC | 5,966,527 | $36,873,000 | 1.30% |
| FRAZIER MANAGEMENT LLC | 2,544,500 | $15,725,000 | 1.26% |